| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Cangrelor vs. glycoprotein IIb/IIIa inhibitors during percutaneous coronary intervention
|
Yerasi, Charan
|
|
|
238 |
C |
p. 59-65
|
artikel
|
| 2 |
Clinical features and outcomes in patients with cardiogenic shock complicating acute myocardial infarction: early vs recent experience with impella
|
Singh, Hemindermeet
|
|
|
238 |
C |
p. 66-74
|
artikel
|
| 3 |
Comparative effectiveness of team-based care with a clinical decision support system versus team-based care alone on cardiovascular risk reduction among patients with diabetes: Rationale and design of the D4C trial
|
Shi, Xiulin
|
|
|
238 |
C |
p. 45-58
|
artikel
|
| 4 |
Editorial Board
|
|
|
|
238 |
C |
p. iii
|
artikel
|
| 5 |
Effects of the PCSK9 antibody alirocumab on coronary atherosclerosis in patients with acute myocardial infarction: a serial, multivessel, intravascular ultrasound, near-infrared spectroscopy and optical coherence tomography imaging study–Rationale and design of the PACMAN-AMI trial
|
Zanchin, Christian
|
|
|
238 |
C |
p. 33-44
|
artikel
|
| 6 |
Electronic health record risk score provides earlier prognostication of clinical outcomes in patients admitted to the cardiac intensive care unit
|
Kunitomo, Yukiko
|
|
|
238 |
C |
p. 85-88
|
artikel
|
| 7 |
Financial burden, distress, and toxicity in cardiovascular disease
|
Slavin, Samuel D.
|
|
|
238 |
C |
p. 75-84
|
artikel
|
| 8 |
Individuals aged 1-64 years with documented congenital heart defects at healthcare encounters, five U.S. surveillance sites, 2011-2013
|
Jill Glidewell, M.
|
|
|
238 |
C |
p. 100-108
|
artikel
|
| 9 |
Information for Readers
|
|
|
|
238 |
C |
p. iv
|
artikel
|
| 10 |
Long-term prognostic outcomes and implication of oral anticoagulants in patients with new-onset atrial fibrillation following st-segment elevation myocardial infarction
|
Madsen, Jasmine Melissa
|
|
|
238 |
C |
p. 89-99
|
artikel
|
| 11 |
Neighborhood education status drives racial disparities in clinical outcomes in PPCM
|
Getz, Kelly D.
|
|
|
238 |
C |
p. 27-32
|
artikel
|
| 12 |
Randomized clinical trial to evaluate a routine full anticoagulation Strategy in Patients with Coronavirus Infection (SARS-CoV2) admitted to hospital: Rationale and design of the ACTION (AntiCoagulaTlon cOroNavirus)–Coalition IV trial
|
Lopes, Renato D.
|
|
|
238 |
C |
p. 1-11
|
artikel
|
| 13 |
Rationale and design of a large population study to validate software for the assessment of atrial fibrillation from data acquired by a consumer tracker or smartwatch: The Fitbit heart study
|
Lubitz, Steven A.
|
|
|
238 |
C |
p. 16-26
|
artikel
|
| 14 |
Table of Contents
|
|
|
|
238 |
C |
p. i-ii
|
artikel
|
| 15 |
Validity of different dose reduction criteria for apixaban
|
Hawkins, Nathaniel M.
|
|
|
238 |
C |
p. 12-15
|
artikel
|
Tijdschrift beschrijving